Bastian Schilling

Bastian Schilling

Josef Schneider Str. 2
Wuerzburg, BY 97080, Germany

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 203 publications

Current challenges in standardising classification and management of locally advanced cutaneous squamous cell carcinoma.

Current challenges in standardising classification and management of locally advanced cutaneous squamous cell carcinoma.

Journal: European journal of cancer (Oxford, England : 1990)
Published: April 18, 2026

Psoriasis Area and Severity Index Training via Virtual Reality Application: New Way of Effective Teaching.

Psoriasis Area and Severity Index Training via Virtual Reality Application: New Way of Effective Teaching.

Journal: Dermatology (Basel, Switzerland)
Published: December 17, 2025

IO102-IO103 immune-modulatory cancer vaccine and pembrolizumab in melanoma.

IO102-IO103 immune-modulatory cancer vaccine and pembrolizumab in melanoma.

Journal: Annals of oncology : official journal of the European Society for Medical Oncology
Published: October 31, 2025

Retraction Note: sFRP2 in the aged microenvironment drives melanoma metastasis and therapy resistance.

Retraction Note: sFRP2 in the aged microenvironment drives melanoma metastasis and therapy resistance.

Journal: Nature
Published: October 30, 2025

Targeting the G-protein-coupled estrogen receptor: a novel therapeutic strategy in cutaneous T-cell lymphoma.

Targeting the G-protein-coupled estrogen receptor: a novel therapeutic strategy in cutaneous T-cell lymphoma.

Journal: Blood neoplasia
Published: October 28, 2025

An updated European organization for research and treatment of cancer (EORTC) protocol for pathological evaluation of sentinel lymph nodes for merkel cell carcinoma (MCC).

An updated European organization for research and treatment of cancer (EORTC) protocol for pathological evaluation of sentinel lymph nodes for merkel cell carcinoma (MCC).

Journal: European journal of cancer (Oxford, England : 1990)
Published: October 06, 2025

Grand SLAM study protocol: a prospective randomised multicentre study of shortened versus standard duration adjuvant immune checkpoint inhibition for stage IIB-C, III and IV cutaneous melanoma.

Grand SLAM study protocol: a prospective randomised multicentre study of shortened versus standard duration adjuvant immune checkpoint inhibition for stage IIB-C, III and IV cutaneous melanoma.

Journal: BMC cancer
Published: September 30, 2025

Perioperative Pembrolizumab in Locally Advanced Melanoma: A Real-world Single-centre Retrospective Study.

Perioperative Pembrolizumab in Locally Advanced Melanoma: A Real-world Single-centre Retrospective Study.

Journal: Acta dermato-venereologica
Published: September 07, 2025

Infliximab is a safe and effective treatment in steroid-refractory immune-related hepatitis.

Infliximab is a safe and effective treatment in steroid-refractory immune-related hepatitis.

Journal: Journal for immunotherapy of cancer
Published: September 03, 2025

Metabolic determinants of cancer immunotherapy outcomes identified by plasma profiling.

Metabolic determinants of cancer immunotherapy outcomes identified by plasma profiling.

Journal: Nature medicine
Published: August 12, 2025

Melanoma of unknown primary shows an oncogenic pattern and clinical course of sun-exposed melanoma.

Melanoma of unknown primary shows an oncogenic pattern and clinical course of sun-exposed melanoma.

Journal: The British journal of dermatology
Published: August 06, 2025

Outcome of systemic therapy in patients with advanced rare skin cancers: A retrospective multicenter DeCOG study of 209 patients.

Outcome of systemic therapy in patients with advanced rare skin cancers: A retrospective multicenter DeCOG study of 209 patients.

Journal: European journal of cancer (Oxford, England : 1990)
Published: August 03, 2025
Showing 1-12 of 203

Last Updated: 09/26/2026